Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Return on Assets (2016 - 2025)

Cytosorbents (CTSO) has disclosed Return on Assets for 13 consecutive years, with 0.25% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 29.0% year-over-year to 0.25%, compared with a TTM value of 0.25% through Sep 2025, down 29.0%, and an annual FY2024 reading of 0.33%, down 20.0% over the prior year.
  • Return on Assets was 0.25% for Q3 2025 at Cytosorbents, up from 0.33% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.04% in Q3 2024 and bottomed at 0.62% in Q3 2022.
  • Average Return on Assets over 5 years is 0.29%, with a median of 0.27% recorded in 2021.
  • The sharpest move saw Return on Assets tumbled -45bps in 2022, then surged 51bps in 2024.
  • Year by year, Return on Assets stood at 0.27% in 2021, then tumbled by -97bps to 0.52% in 2022, then skyrocketed by 72bps to 0.15% in 2023, then tumbled by -130bps to 0.33% in 2024, then rose by 24bps to 0.25% in 2025.
  • Business Quant data shows Return on Assets for CTSO at 0.25% in Q3 2025, 0.33% in Q4 2024, and 0.04% in Q3 2024.